Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.69M Buy
38,739
+1,556
+4% +$98.7K ﹤0.01% 1659
2023
Q4
$2.06M Buy
37,183
+2,704
+8% +$122K ﹤0.01% 1858
2023
Q3
$1.24M Sell
34,479
-474
-1% -$16.3K ﹤0.01% 2152
2023
Q2
$1.11M Buy
34,953
+22,059
+171% +$843K ﹤0.01% 2317
2023
Q1
$397K Buy
12,894
+1,264
+11% +$38.3K ﹤0.01% 2869
2022
Q4
$360K Buy
11,630
+11,465
+6,948% +$263K ﹤0.01% 2944
2022
Q3
$3K Buy
165
+154
+1,400% +$2.95K ﹤0.01% 3661
2022
Q2
$0 Buy
+11
New +$142 ﹤0.01% 3878

Other funds holding ACLX

Credit Suisse's ACLX Position: Q1 2024 in Review

Credit Suisse increased its Arcellx (ACLX) stake by 4.2% in Q1 2024, buying an estimated $98.7K and bringing the position to 38,739 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Credit Suisse first reported a position in ACLX in Q2 2022 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold ACLX as of Q1 2024.

  • Credit Suisse held 38,739 shares of Arcellx worth $2.69M as of Q1 2024.
  • Credit Suisse bought 1,556 Arcellx shares in Q1 2024, an estimated $98.7K.
  • Arcellx made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1659 holding.
  • Credit Suisse first reported a position in Arcellx in Q2 2022 and has held it in 8 quarters since.
  • 183 funds tracked by Wall St. Rank held Arcellx as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.